Continuing our Life-Long Commitment to Rare Disease Patients Around the World
As our global community continues to navigate the impact of COVID-19, CENTOGENE remains fully open and operational, underlining our continued commitment to patients globally.
ORDER ON CENTOPORTAL®

Back
Img Alt Text

Transforming Global Genetic Data into Medical Decisions

We are a global leader in rare disease diagnosis and research by transforming real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies

Rare Disease Day 2021

28 February was
Rare Disease Day 2021!

Featuring our virtual conference on COVID-19 impacts and benefits of international diagnostic cooperation for patients all over the world.

Read More or Watch on Demand

Rare Disease Day 2021

On 28 February was our
Rare Disease Filmfestival 2021!

Watch our virtual festival of prize-winning films selected from 120 countries honoring and redefining what it means to be rare!

Read More or Watch on Demand

CENTOGENE - Revolutionising Genetic Solutions

Explore how CENTOGENE is revolutionizing genetic solutions for patients worldwide

Know More

Coronavirus Testing With CENTOGENE

Coronavirus Testing With CENTOGENE

Enabling you to get back to normal with our range of SARS-CoV-2 testing solutions for individuals and businesses

Read More

Improved Travel With Coronavirus Testing

The Latest Insights Into COVID-19

Keeping you up to date with the most recent news and scientific developments amid the Coronavirus pandemic

Read More

Our goal: providing precise medical diagnosis of inherited diseases at the earliest possible moment; transforming medical expertise and analytical information into actionable results for physicians, patients, and pharmaceutical partners.

Our commitment: life-long support for our patients and partners - driven by the continuous improvement of our diagnostic quality and therapeutic options for individual patients.

Centogene’s latest Scientific Publications

A Dispute on Rare Disease Diagnostic Offerings

CENTOGENE was amongst the first providers of diagnostic Whole Genome Sequencing (WGS) and…

An Unusual Kind of Repeat Expansion Disorder

Repeat expansions are the cause of Huntington’s disease and several forms of ataxia. The…

Diagnostic Relevance of Intronic Variants

Proper splicing of mRNA requires certain DNA sequence motifs. Since these motifs are very…

Exemplifying the Strengths of Genome Sequencing

Certain genetic variants are easily missed by Exome Sequencing (ES), but readily detected…

Utilization of CentoMD® in Scientific Settings

The interpretation of newly observed genetic variants that are suspected to cause disease…

Turning Rare Disease Networks into Knowledge

CENTOGENE’s well-recognized expertise in Gaucher disease (GD) has helped to establish a…

Genetic Cause of Impaired Neurodevelopment

Development of the nervous system is a complex process, with NEUROG1 being one out of many…

Exemplifying the High Value of CentoMD®

Rare disease research usually focuses on pathogenic genetic variants. The lack of a…

A Rare Genetic Disease in Which Symptoms Naturally Improve

While most genetic disorders progress from mild to severe, a certain form of muscle…

Genetic Stratification of Patients with Parkinson’s Disease

While Parkinson’s disease (PD) is clinically homogeneous, it can result from a multitude…

Customer Feedback

Give feedback

Newsletter subscription

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 04. März 2021

  • Ab nächster Woche bis zu den Pfingstferien bietet CENTOGENE den etwa 30.000 Schülern...
Read more

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 22. Februar 2021

  • Epidemiologische Studie verfolgt das Ziel, das spezifische...
Read more

Virtuelle Konferenz und -Filmfestival 2021 am 28. Februar 2021

Read more

Virtual Conference and Filmfestival on February 28, 2021

Read more

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 16. Februar 2021

  • Im Zuge der aufgetretenen SARS-CoV-2 Mutationen aus Großbritannien und Südafrika hat...
Read more

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 15. Februar 2021

  • Das Walk-In-Testzentrum an CENTOGENEs Firmenhauptsitz, am Strande 7 in Rostock, wird...
Read more

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 03. Februar 2021

  • CENTOGENE weitet sein SARS-CoV-2-Testangebot auf ein zweites Testzentrum in...
Read more

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 26. Januar 2021

  • Im Zuge der aufgetretenen SARS-CoV-2 Mutationen aus Großbritannien und Südafrika hat...
Read more

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 18. Januar 2021

  • Das Walk-In-Testzentrum im Flughafen Düsseldorf wurde vom Terminal C zur...
Read more